Overview

Driving Simulation to Assess Non-Sedative Effects of Tolperisone

Status:
Completed
Trial end date:
2018-01-30
Target enrollment:
Participant gender:
Summary
This is a randomized blinded study to assess the sedative effect of 150 mg TID tolperisone and 10 mg TID cyclobenzaprine compared to placebo on simulated driving performance and cognitive functioning in healthy adult volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Neurana Pharmaceuticals, Inc.
Collaborator:
Cognitive Research Corporation
Treatments:
Amitriptyline
Cyclobenzaprine
Tolperisone